Government initiatives will escalate the North American COVID-19 Diagnostics Market in 2020

The North American COVID-19 diagnostics industry will see the considerable decline of 24.7% during the forecast period. North America is anticipated to make huge contribution to the global COVID-19 diagnostics market in 2020; however, the market will decline during the forecast period. In the US, CDC is collaborating with commercial laboratories to perform and publish results from a large-scale geographic seroprevalence survey that has tested de-identified clinical blood specimens from Connecticut, Louisiana, Minnesota, Missouri, New York City, Philadelphia, San Francisco, South Florida, Utah and Western Washington State for SARS-CoV-2 antibodies. The US conducted studies in 10 sites from March 23, 2020, to May 12, 2020, which aimed to test nearly 1,800 samples collected from each of these 10 areas, nearly every 3–4 weeks. As per the results of the data from CDC partnership with commercial laboratories to test de-identified clinical blood specimens for antibodies in Connecticut, South Florida, the New York City area, Missouri, Utah, and western Washington state, it was found that SARS-CoV-2 infections may be 10 times higher than the reported number of cases.

Browse the full report description North American COVID-19 Diagnostics Market Size, Share & Trends Analysis Report by Type (Instruments, Reagents & Kits, and Laboratory Testing Services), by Technology Type (PCR Test, Antigen Test, Serology Test, and Rapid/ PoC Test), by Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Blood, Urine, Saliva, and Others), and by End-User (Laboratories, Hospitals, Diagnostic Centers & Clinics, and Research Institutes) and Forecast, 2020-2026 at https://www.omrglobal.com/industry-reports/north-american-covid-19-diagnostics-market

In April 2020, the US National Institutes of Health (NIH) announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for COVID-19. The program aims to increase the US capacity for SARS-CoV-2 testing. The Ontario COVID-19 Rapid Research Fund is offering colleges, universities, research institutes and academic hospitals with funding to contribute to global efforts to contain the COVID-19 pandemic by making research related to new diagnostics procedure. Abbott Laboratories Inc., Adt Biotech Sdn Bhd, Beckman Coulter Inc., and Cellex Inc. are some of the key players operating in the region. The considerable presence of major market players in the region is further anticipated to propel the market growth.

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment/region dominates the market in base year?
• Which segment/region will project fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?

o Recovery Timeline

o Deviation from pre-COVID-19 

o Most affected region/segment

o Recommendations 

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

North American COVID-19 Diagnostics Market – Segmentation

By Type

• Instruments
• Reagents & Kits
• Laboratory Testing Services

By Technology Type

• PCR Test
• Antigen Test

o Chromatographic Immunoassay

o Fluorescent Immunoassay

o Chemiluminescent Immunoassay

• Serology Test

o Enzyme-Linked Immunosorbent Assay (ELISA)

o Neutralization

o Chemiluminescent Immunoassay

• Rapid/ PoC Test

By Sample Type

• Oropharyngeal & Nasopharyngeal Swabs
• Blood
• Urine
• Saliva
• Others (Sperm)

By End-Users

• Laboratories
• Hospitals
• Diagnostic Centers & Clinics
• Research Institutes

North American COVID-19 Diagnostics Market – Segmentation by Geography

• US
• Canada